MiMedx EpiFix Receives Coverage From Aetna |
December 28, 2016 | December 2016 Bond Updates |
MARIETTA, Ga., Dec. 27, 2016 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine,... |
View more at: http://www.prnewswire.com/news-releases/mimedx-epifix-receives-coverage-from-aetna-300383723.html |
Related News |
|